PHARMABEES vs LAURUSLABS: Stock Comparison
Head-to-head financial and trading comparison between PHARMABEES (PHARMABEES) and Laurus Labs Limited (LAURUSLABS) in the Cross-Sector Peers sector.
PHARMABEES
NSE: PHARMABEESLAURUSLABS
NSE: LAURUSLABSKey Metrics Comparison Table
| Metric | PHARMABEES | LAURUSLABS | Edge / Winner |
|---|---|---|---|
| Current Market Price (CMP) | ₹26.72 | ₹2,036.60 | — |
| 1-Year Price Return | +16.07% | +80.31% | LAURUSLABS (64.24% higher) |
| 52-Week High | ₹27.89 | ₹2,052.80 | — |
| 52-Week Low | ₹23.00 | ₹1,090.45 | — |
| 30-Day Annualized Volatility | 14.23% | 27.19% | PHARMABEES (Steadier) |
| 30-Day Average Daily Volume | 4,400,662 | 2,830,400 | PHARMABEES (Higher Liquidity) |
| Statutory Cost to Trade ₹1 Lakh | ₹118.50 | ₹118.50 | Identical statutory tariff |
Frequently Asked Questions
Between PHARMABEES and LAURUSLABS, which stock gave better returns over the last year?
LAURUSLABS has outperformed PHARMABEES over the past 12 months with a gain of 80.31% compared to 16.07%.
Which stock is less volatile: PHARMABEES or LAURUSLABS?
PHARMABEES demonstrated lower price volatility (14.23% annualized) compared to LAURUSLABS (27.19%). Lower volatility generally indicates steadier price action during market downturns.
What is the statutory cost to buy ₹1,00,000 of PHARMABEES vs LAURUSLABS?
Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).
Are PHARMABEES and LAURUSLABS direct sector competitors?
Yes, both companies operate within the Cross-Sector Peers sector in India and are actively tracked as sector peers by institutional and retail market participants.